Trial Profile
Sequencing Treatments for Mothers With ADHD and Their At - Risk Children
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 17 Sep 2020
Price :
$35
*
At a glance
- Drugs Lisdexamfetamine (Primary)
- Indications Attention-deficit hyperactivity disorder
- Focus Therapeutic Use
- Acronyms TMF
- 08 Sep 2020 Results published in the Journal of Clinical Psychiatry
- 18 Apr 2018 Status changed from recruiting to completed.
- 06 Jul 2016 Planned End Date changed from 1 Dec 2016 to 1 Apr 2017.